{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,5]],"date-time":"2026-09-05T14:17:37Z","timestamp":1788617857495,"version":"build-2803163510"},"reference-count":19,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["20K07165"],"award-info":[{"award-number":["20K07165"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005865","name":"Mochida Memorial Foundation for Medical and Pharmaceutical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005865","id-type":"DOI","asserted-by":"publisher"}]},{"name":"The Research Foundation for Pharmaceutical Sciences"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Pharm Health Care Sci"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Background<\/jats:title>\n                <jats:p>The syndrome of inappropriate secretion of antidiuretic hormone (SIADH) is the most frequent cause of hyponatremia in patients with cerebrovascular disease, and is often treated with oral salt tablets. However, we have shown that osmolality-dependent variations in gastrointestinal (GI) fluid volume can alter the concentration of a poorly permeable drug in the GI tract, potentially affecting its absorption. Here, we examined the effect of ingestion of hyperosmotic solution (10% NaCl) on drug concentration and absorption in the GI tract.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>The effects of osmolality on luminal fluid volume and drug absorption in rat intestine (jejunum, ileum and colon) were examined by means of an in situ closed loop method using fluorescein isothiocyanate-dextran 4000 (FD-4) and atenolol. In vivo absorption in rats was determined by measuring the plasma concentration after oral administration of the test compounds dissolved in purified water or hyperosmotic solution (10% NaCl).<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Administration of hyperosmotic solution directly into the GI tract significantly increased the GI fluid volume, owing to secretion of water into the lumen. After administration in hyperosmotic solution, the luminal concentration of non-permeable FD-4 was significantly lower than the initial dosing concentration, whereas after administration in purified water, the luminal concentration exceeded the initial concentration. The fraction absorbed of atenolol was markedly lower after administration in hyperosmotic solution than after administration in purified water. An in vivo pharmacokinetic study in rats was consistent with these findings.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusions<\/jats:title>\n                <jats:p>Administration of hyperosmotic NaCl solution increased GI fluid volume and reduced the plasma level of orally administered atenolol. This may imply that oral salt tablets used to treat hyponatremia in SIADH patients could decrease the intestinal absorption of concomitantly administered drugs, resulting in lower plasma exposure.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1186\/s40780-021-00212-z","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:08:58Z","timestamp":1630454938000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Influence of osmolality on gastrointestinal fluid volume and drug absorption: potential impact on oral salt supplementation"],"prefix":"10.1186","volume":"7","author":[{"given":"Miyuki","family":"Takemura","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhisa","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikumi","family":"Tamai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1472-7449","authenticated-orcid":false,"given":"Yoshiyuki","family":"Shirasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2021,9,1]]},"reference":[{"issue":"9","key":"212_CR1","doi-asserted-by":"publisher","first-page":"2889","DOI":"10.1016\/j.xphs.2017.04.030","volume":"106","author":"K Ichijo","year":"2017","unstructured":"Ichijo K, Oda R, Ishihara M, Okada R, Moteki Y, Funai Y, et al. Osmolality of orally administered solutions influences luminal water volume and drug absorption in intestine. J Pharm Sci. 2017;106(9):2889\u201394. https:\/\/doi.org\/10.1016\/j.xphs.2017.04.030.","journal-title":"J Pharm Sci"},{"issue":"4","key":"212_CR2","doi-asserted-by":"publisher","first-page":"386","DOI":"10.1124\/dmd.118.084483","volume":"47","author":"Y Funai","year":"2019","unstructured":"Funai Y, Shirasaka Y, Ishihara M, Takemura M, Ichijo K, Kishimoto H, et al. Effect of osmolality on the pharmacokinetic interaction between apple juice and atenolol in rats. Drug Metab Dispos. 2019;47(4):386\u201391. https:\/\/doi.org\/10.1124\/dmd.118.084483.","journal-title":"Drug Metab Dispos"},{"key":"212_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfu040","volume":"29","author":"G Spasovski","year":"2014","unstructured":"Spasovski G, Vanholder R, Allolio B, Annane D, Ball S, Bichet D, et al. Clinical practice guideline on diagnosis and treatment of hyponatraemia. Nephrol Dial Transplant. 2014;29:1\u201339.","journal-title":"Nephrol Dial Transplant"},{"issue":"1","key":"212_CR4","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1111\/ane.12938","volume":"138","author":"S Jin","year":"2018","unstructured":"Jin S, Long Z, Wang W, Jiang B. Hyponatremia in neuromyelitis optica spectrum disorders: literature review. Acta Neurol Scand. 2018;138(1):4\u201311. https:\/\/doi.org\/10.1111\/ane.12938.","journal-title":"Acta Neurol Scand"},{"issue":"5","key":"212_CR5","doi-asserted-by":"publisher","first-page":"599","DOI":"10.1248\/yakushi.19-00246","volume":"140","author":"Y Shirasaka","year":"2020","unstructured":"Shirasaka Y. Quantitative analysis of gastrointestinal physiology for better prediction of oral drug absorption and interaction. Yakugaku-Zasshi. 2020;140(5):599\u2013608. https:\/\/doi.org\/10.1248\/yakushi.19-00246.","journal-title":"Yakugaku-Zasshi."},{"issue":"7","key":"212_CR6","doi-asserted-by":"publisher","first-page":"687","DOI":"10.1111\/j.2042-7158.1997.tb06093.x","volume":"49","author":"U Fagerholm","year":"1997","unstructured":"Fagerholm U, Lindahl A, Lennern\u00e4s H. Regional intestinal permeability in rats of compounds with different physicochemical properties and transport mechanisms. J Pharm Pharmacol. 1997;49(7):687\u201390. https:\/\/doi.org\/10.1111\/j.2042-7158.1997.tb06093.x.","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"212_CR7","doi-asserted-by":"publisher","first-page":"3843","DOI":"10.1002\/jps.22586","volume":"100","author":"Y Shirasaka","year":"2011","unstructured":"Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. Differential effect of grapefruit juice on intestinal absorption of statins due to inhibition of organic anion transporting polypeptide and\/or P-glycoprotein. J Pharm Sci. 2011;100(9):3843\u201353. https:\/\/doi.org\/10.1002\/jps.22586.","journal-title":"J Pharm Sci"},{"issue":"10","key":"212_CR8","doi-asserted-by":"publisher","first-page":"2141","DOI":"10.1007\/s11095-010-0216-5","volume":"27","author":"Y Shirasaka","year":"2010","unstructured":"Shirasaka Y, Suzuki K, Nakanishi T, Tamai I. Intestinal absorption of HMG-CoA reductase inhibitor pravastatin mediated by organic anion transporting polypeptide. Pharm Res. 2010;27(10):2141\u20139. https:\/\/doi.org\/10.1007\/s11095-010-0216-5.","journal-title":"Pharm Res"},{"issue":"3","key":"212_CR9","doi-asserted-by":"publisher","first-page":"560","DOI":"10.1007\/s11095-008-9771-4","volume":"26","author":"Y Shirasaka","year":"2009","unstructured":"Shirasaka Y, Li Y, Shibue Y, Kuraoka E, Spahn-Langguth H, Kato Y, et al. Concentration-dependent effect of naringin on intestinal absorption of \u03b21-adrenoceptor antagonist talinolol mediated by P-glycoprotein and organic anion transporting polypeptide (Oatp). Pharm Res. 2009;26(3):560\u20137. https:\/\/doi.org\/10.1007\/s11095-008-9771-4.","journal-title":"Pharm Res"},{"key":"212_CR10","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1007\/BF01062109","volume":"6","author":"K Yamaoka","year":"1978","unstructured":"Yamaoka K, Nakagawa T, Uno T. Statistical moments in pharmacokinetics. J Pharmacokinet Biopharm. 1978;6:547\u201358.","journal-title":"J Pharmacokinet Biopharm"},{"key":"212_CR11","unstructured":"The Japanese Society for Hypothalamic and Pituitary tumors. Guideline for the diagnosis and treatment of the syndrome of inappropriate secretion of antidiuretic hormone (SIADH). 2011. https:\/\/square.umin.ac.jp\/kasuitai\/guidance\/SIADH.pdf (in Japanese). Accessed 4\/2021."},{"issue":"1","key":"212_CR12","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1172\/JCI116933","volume":"93","author":"C Bookstein","year":"1994","unstructured":"Bookstein C, DePaoli AM, Xie Y, Niu P, Musch MW, Rao MC, et al. Na+\/H+ exchangers, NHE-1 and NHE-3, of rat intestine. Expression and localization. J Clin Invest. 1994;93(1):106\u201313. https:\/\/doi.org\/10.1172\/JCI116933.","journal-title":"J Clin Invest"},{"issue":"2","key":"212_CR13","doi-asserted-by":"publisher","first-page":"G358","DOI":"10.1152\/ajpgi.00151.2010","volume":"299","author":"C Talbot","year":"2010","unstructured":"Talbot C, Lytle C. Segregation of Na\/H exchanger-3 and cl\/HCO3 exchanger SLC26A3 (DRA) in rodent cecum and colon. Am J Physiol Gastrointest Liver Physiol. 2010;299(2):G358\u201367. https:\/\/doi.org\/10.1152\/ajpgi.00151.2010.","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"212_CR14","first-page":"1","volume":"10","author":"JL Wang","year":"2019","unstructured":"Wang JL, Zhao L, Zhu J, Wang DK, Ren MJ, Wang M, et al. Expression, localization, and effect of high salt intake on electroneutral Na+\/HCO3\u2212 cotransporter NBCn2 in rat small intestine: implication in intestinal NaCl absorption. Front Physiol. 2019;10:1\u201311.","journal-title":"Front Physiol"},{"issue":"1","key":"212_CR15","doi-asserted-by":"publisher","first-page":"G29","DOI":"10.1152\/ajpgi.1996.270.1.G29","volume":"270","author":"WA Hoogerwerf","year":"1996","unstructured":"Hoogerwerf WA, Tsao SC, Devuyst O, Levine SA, Yun CHC, Yip JW, et al. NHE2 and NHE3 are human and rabbit intestinal brush-border proteins. Am J Physiol - Gastrointest Liver Physiol. 1996;270(1):G29\u201341. https:\/\/doi.org\/10.1152\/ajpgi.1996.270.1.G29.","journal-title":"Am J Physiol - Gastrointest Liver Physiol."},{"key":"212_CR16","doi-asserted-by":"publisher","first-page":"261","DOI":"10.1146\/annurev-physiol-012110-142244","volume":"73","author":"A Kato","year":"2011","unstructured":"Kato A, Romero MF. Regulation of electroneutral NaCl absorption by the small intestine. Annu Rev Physiol. 2011;73:261\u201328.","journal-title":"Annu Rev Physiol"},{"issue":"9","key":"212_CR17","doi-asserted-by":"publisher","first-page":"3039","DOI":"10.1021\/mp500210c","volume":"11","author":"DM Mudie","year":"2014","unstructured":"Mudie DM, Murray K, Hoad CL, Pritchard SE, Garnett MC, Amidon GL, et al. Quantification of gastrointestinal liquid volumes and distribution following a 240 mL dose of water in the fasted state. Mol Pharm. 2014;11(9):3039\u201347. https:\/\/doi.org\/10.1021\/mp500210c.","journal-title":"Mol Pharm"},{"issue":"6","key":"212_CR18","doi-asserted-by":"publisher","first-page":"2261","DOI":"10.1021\/mp300469m","volume":"10","author":"T Takashima","year":"2013","unstructured":"Takashima T, Shingaki T, Katayama Y, Hayashinaka E, Wada Y, Kataoka M, et al. Dynamic analysis of fluid distribution in the gastrointestinal tract in rats: positron emission tomography imaging after oral administration of nonabsorbable marker, [18F] deoxyfluoropoly (ethylene glycol). Mol Pharm. 2013;10(6):2261\u20139. https:\/\/doi.org\/10.1021\/mp300469m.","journal-title":"Mol Pharm"},{"issue":"9","key":"212_CR19","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1007\/s40618-016-0463-3","volume":"39","author":"M Cuesta","year":"2016","unstructured":"Cuesta M, Garrahy A, Thompson CJ. SIAD: practical recommendations for diagnosis and management. J Endocrinol Invest. 2016;39(9):991\u20131001. https:\/\/doi.org\/10.1007\/s40618-016-0463-3.","journal-title":"J Endocrinol Invest"}],"container-title":["Journal of Pharmaceutical Health Care and Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-021-00212-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s40780-021-00212-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s40780-021-00212-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:14:13Z","timestamp":1630455253000},"score":1,"resource":{"primary":{"URL":"https:\/\/jphcs.biomedcentral.com\/articles\/10.1186\/s40780-021-00212-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,9,1]]},"references-count":19,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["212"],"URL":"https:\/\/doi.org\/10.1186\/s40780-021-00212-z","relation":{},"ISSN":["2055-0294"],"issn-type":[{"value":"2055-0294","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,9,1]]},"assertion":[{"value":"2 April 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 June 2021","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 September 2021","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"All animal experimental protocols were reviewed and approved by the Committee of Animal Care and Welfare of Tokyo University of Pharmacy and Life Sciences and Kanazawa University.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare that they have no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"29"}}